TY - JOUR T1 - Obesity and Race Alter Gene Expression in Skin JF - medRxiv DO - 10.1101/2020.06.02.20120469 SP - 2020.06.02.20120469 AU - Jeanne M. Walker AU - Sandra Garcet AU - Jose O. Aleman AU - Christopher E. Mason AU - David Danko AU - Simone Zuffa AU - Jonathan R. Swann AU - James Krueger AU - Jan L. Breslow AU - Peter R. Holt Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/06/05/2020.06.02.20120469.abstract N2 - Obesity is accompanied by dysfunction of many organs, but effects on the skin have received little attention. We studied differences in epithelial thickness by histology and gene expression by Affymetrix gene arrays and PCR in the skin of 10 obese (BMI 35-50) and 10 normal weight (BMI 18.5-26.9) postmenopausal women paired by age and race. Epidermal thickness did not differ with obesity but the expression of genes encoding proteins associated with skin blood supply and wound healing were altered. In the obese, many gene expression pathways were broadly downregulated and subdermal fat showed pronounced inflammation. There were no changes in skin microbiota or metabolites. African American subjects differed from Caucasians with a trend to increased epidermal thickening. In obese African Americans, compared to obese Caucasians, we observed altered gene expression that may explain known differences in water content and stress response. African Americans showed markedly lower expression of the gene encoding the cystic fibrosis transmembrane regulator characteristic of the disease cystic fibrosis. The results from this preliminary study may explain the functional changes found in the skin of obese subjects and African Americans.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis study does not involve a health-related intervention and therefore does not meet the criteria for registration with ClinicalTrials.govFunding StatementJMW received research grants from RUCCTS grant#ULTR001866 from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) Program. JOA received research grants from the Center for Diseases of the Digestive System and Sackler Center for Bionutrition at Rockefeller Universtiy, AHA 17-SFRN33520045 and K08-DK117064 (NIH) at NYU Langone Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The institutional review board of the Rockefeller University Hospital, and the Advisory Committee for Clinical and Translational Research approved the protocol JWA-0921 after full committee review on 11/30/2016, and thereafter annually.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is provided in the manuscript submitted. The gene expression data has been downloaded into the GEO repository. The accession number is pending. https://www.ncbi.nlm.nih.gov/geo ER -